Benign Breast Disease
17
1
4
9
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 17 trials
100.0%
+13.5% vs benchmark
6%
1 trials in Phase 3/4
11%
1 of 9 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 9 completed trials
Clinical Trials (17)
Prospective Study of MAstectomy With Reconstruction Including Robot Endoscopic Surgery
Johns Hopkins Breast Cancer Program Longitudinal Repository
Evaluating Scaleup of an Adapted Breast Cancer Early Diagnosis Program in Rwanda
Development of Assist Tool for Breast Examination Using the Principle of Ultrasonic Sensor
An Investigation Into Dielectric Assessment of Permittivity and Conductivity in Human Using a Novel Electrical Capacitance Tomography Scanner
Effectiveness Validation of CELBREA® in Symptomatic Women or With Diagnostic Doubt of Breast Pathology (DETECT-BH)
The Development of Quantitative Ultrasound Imaging Software Platform
VITamin D and OmegA-3 TriaL: Effects on Mammographic Density and Breast Tissue
Promoting Earlier Detection of Breast Cancer in Rwanda: Scaleup in the National Health Care System
REGENERA Implant in Excised Non-Malignant Breast Lesions
Central Mammary Duct Excision; How to Improve the Outcome?
Risk Factors for Benign Breast Disease
Genetics of Mammographic Appearances and Patterns (The GenMap Study)
China CellSearch Study
Effects of Tamoxifen in Premenopausal Women With Benign Breast Disease Not at High-Risk of Developing Breast Cancer
Prolactin Receptor and Breast Diseases
Nuclear Morphology of Breast Cells in Ductal Lavage